Skip to main content
Have a personal or library account? Click to login
Semicarbazone – a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design Cover

Semicarbazone – a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design

Open Access
|Nov 2012

References

  1. 1. M. Meonardi and T. Ustun, The global burden of epilepsy,(2002) 21_25; DOI: 10. 1046/j.1528-1157.43.s.6.11.x.
  2. 2. R. Sridharan and B. N. Murthy, Relevance and pattern of epilepsy in India,(1999) 631_636; DOI: 10.1111/j.1528-1157.1999.tb05566x.
  3. 3. G. F. Carl and M. L. Smith, Phenytoin-folate interaction differing effect of the sodium salt and the free acid of phenytoin,(1992) 372_375; DOI: 10.1111/j.1528-1157.1992tb02330x.
  4. 4. P. Kwan and M. J. Brodie, Phenobarbital for the treatment of epilepsy in the 21st century, a critical review,(2004) 1141_1149; DOI: 10.1111/j.0013-9580.2004.12704.x.
  5. 5. S. D. Shorvon, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959_2009,(suppl. 3) (2009) 93_130; DOI: 10.1111/j.1528-1167.2009.02042.x.
  6. 6. A. C. Foster and J. A. Kemp, Glutamate and GABA-based CNS therapeutics,(2006) 7_17.
  7. 7. M. Mazza, G. Della Marcla and M. DiNicola, Oxacarbazepine improves mood in the patients with epilepsy,(2007) 397_401; DOI: 10.1016/j.yebeh.2007.01.003.
  8. 8. J. M. Rho, S. D. Donevan and M. A. Rogawaski, Barbiturate like action of the propanediol dicarbamate felbamate and meprobamate,(1997) 1383_1391.
  9. 9. C. Salome, E. Salome-Grosjean, J. P. Stables and H. Kohn, Merging the structural motifs of functionalized amino acids and alpha amino amides: compounds with significant anticonvulsant activities,(2010) 3756_3771; DOI: 10.1021/jm 100185c.
  10. 10. A. C. Errington, L. Coyne, T. Stohr, N. Selve and G. Lees, Seeking a mechanism of action for the novel anticonvulsant lacosamide,(2006) 1016_1024; DOI: 10.1016/j.neuropharm. 2006.02002.
  11. 11. R. G. Fariello, Safinamide,(2007) 110_116; DOI: 10.1016/j.nurt.2006.11.011.
  12. 12. N. D. Eddington, D. S. Cox, R. R. Roberts, J. P. Stables, C. B. Powells and K. R. Scott, Enaminonesversatile therapeutic pharmacophores, Further advances,(2000) 417_436.
  13. 13. S. N. Pandeya and J. R. Dimmock, Recent evaluation of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities,(1993) 659_666.
  14. 14. H. Beraldo and D. Gambino, The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes,(2004) 31_39.
  15. 15. L. Liu, T. Zeng, M. J. Morris, C. Wallengren, A. L. Clarke, C. A. Reid, S. Petrou and T. J. O’Brien, The mechanism of carbamazepine aggravated of absence seizures,(2006) 790_798; DOI: 10.1124/jpet.106.10496.
  16. 16. S. N. Ghalmi, D. A. Berv, J. Klugman, K. J. Rosenquist and D. J. Hsu, Oxacarbazepine. Treatment of bipolar disorder,(2003) 943_945; DOI: 10.4088/JCP.v64n0813.
  17. 17. C. Dulsat, N. Mealy, R. Castaner and J. Bolos, Eslicarbazepine acetate. Drugs Fut.(2009) 189_199; DOI: 10.1358/dof.2009.034.03.1352675.
  18. 18. D. Schmidt and K. Utech, Progabide for refractory partial epilepsy: A controlled add-on trial,(1986) 217_221.
  19. 19. S. C. Vashishtha, G. A. Zello, K. H. Nienaber, J. Balzarini, E. D. Clercq, J. P. Stables and J. R. Dimmock, Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds,(2004) 27_35.
  20. 20. S. K. Sridhar, S. N. Pandeya, J. P. Stables and A. Ramesh, Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives,(2002) 129_132.
  21. 21. F. D. Popp, Potential anticonvulsants, VII Some hydrazones of indole-3-carboxaldehyde,(1984) 617_619.
  22. 22. J. Jain, Y. Kumar, R. Sinha, R. Kumar and J. Stables, Menthone aryl acid hydrazones: A new class of anticonvulsants,(2011) 56_61.
  23. 23. J. O. McNamara,in(Ed. J. G. Hardman, L. E. Limbird, P. B. Molinoaff and R. W. Ruddon), 9th ed., McGraw Hill, New York 2001, pp. 461_486.
  24. 24. S. Coker, The use of phenacemide for intractable partial complex epilepsy in children,(1986) 230_232; DOI: 10.1016/0887-8994(86)90053-6.
  25. 25. T. R. Browne, „Fosphenytoin (cerebyx),(1997) 1_12; DOI: 10.1097/00002826-199702000-00001.
  26. 26. P. N. Patsalos, Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies,(S9) (2005) 140_144; DOI: 10.1111/j.1528-1167.2005.00326.x.
  27. 27. R. Kaliviainen, K. Eriksson and I. Parviainan, Refractory generalized convulsive status epileptics: a guide to treatment,(2005) 759_768; DOI: 10.2165/00023210-200519090-00003.
  28. 28. J. R. Dimmock, R. N. Pathucode, J. Tuchck and G. B. Baker, Anticonvulsant activities of 4(4’-fluorophenyl) benzaldehyde semicarbazones,(1999) 112_125.
  29. 29. Y. Wang, S. X. Cai and J. F. W. Keanaan, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 638, 947, 28 Oct 2003.
  30. 30. J. R. Dimmock, Semicarbazones having CNS activity and pharmaceutical preparations containing same, U.S. Pat. 5, 741, 818, 21 Apr. 1998.
  31. 31. Y. Wang, S. X. Cai, N. C. Lam, J. F. W. Keanan, VI Ilynin and E Weber, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 613, 803, 2 Sept 2003.
  32. 32. S. X. Cai, N. C. Lam and S. Hongbal, Substituted semicarbazides and the use thereof, U. S. Pat. 6, 281, 211, 28 Aug 2001.
  33. 33. S. N. Pandeya, V. Mishra, P. N. Singh and D. C. Rupainwar, Anticonvulsant activity of thiouriedo derivatives of acetophenone semicarbazone,(1998) 17_22.
  34. 34. V. I. Ilynin, J. D. Ponionis, G. T. Whiteside, J. E. Harrison, M. S. Meason, L. Mork, P. E. Turdin, S. Cooh, R. B. Caster, P. Nguyen, D. S. Hogencamp, S. Olanreqwajn, E. Benzamin and R. N. Woodward, Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy) phenyl]-pyrimidine-4-carboxamide (PPPA): A Potent, broad spectrum state dependent sodium channel blocker for treating painstates,(2006) 1086_1093.
  35. 35. J. R. Dimmock, R. N. Puthucode, M. S. Lo, J. W. Quail, J. Yang and J. P. Stables, Structural modification of the primary amino group of anticonvulsant aryl semicarbazones,(1996) 83_88.
  36. 36. S. N. Pandeya, N. Aggarwal and J. S. Jain, Evaluation of semicarbazones for anticonvulsant and sedative hypnotic properties,(1999) 300_312.
  37. 37. S. N. Pandeya, V. Mishra, I. Ponnilavarsan and J. P. Stables, Anticonvulsant activity ofchlorophenyl substituted arylsemicarbazones - the role of primary terminal amino group,(2000) 283_290.
  38. 38. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted arylsemicarbazones,.(2000) 879_886.
  39. 39. P. Yogeeswari, J. V. Raghvendran, R. Thirumurugan, S. Induja, D. Sriram and J. P. Stables, Synthesis and structure activity relationship on anticonvulsant arylsemicarbazones,(2006) 55_62.
  40. 40. J. Jain, Y. Kumar, J. P. Stables and R. Sinha, Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents,(2010) 44_50.
  41. 41. K. Verma, S. N. Pandeya, V. K. Singh, S. Gupta, P. Prashant, Anurag and G. Bhardwaj, Synthesis and pharmacolgical activity of some substituted menthone semicarbazones and thiosemicarbazone derivatives,(2009) 357_362.
  42. 42. H. P. Singh, C. S. Chauhan, S. N. Pandeya and C. S. Sharma, Chalcone semicarbazone: a new scaffold for antiepileptic drug discovery,(2010) 103_106; DOI: 10.4067/50717-970720 10000 100024.
  43. 43. H. P. Singh, S. N. Pandeya, C. S. Chauhan and C. S. Sharma, Synthesis and pharmacological screening of some novel chalconyl derivatives of substituted phenylsemicarbazide,; DOI: 1007/S00044-000-9277-6.
  44. 44. H. P. Singh, C. S. Chauhan, S. N. Pandeya, C. S. Sharma, B. Srivastava and M. Singhal, Synthesis and pharmacological screening of some novel chloro chalcone semicarbazone derivatives,(2010) 343_357.
  45. 45. S. N. Pandeya, A. K. Agrawal, A. Singh and J. P. Stables, Design and synthesis of semicarbazones and their sioisosteric analogues as potent anticonvulsant: The role of hydrogen bonding,(2003) 15_24.
  46. 46. P. Yogeeswari, D. Sriram, S. N. Pandeya and J. P. Stables, 4-Sulphamoyl semicarbazones with anticonvulsant activity,(2004) 609_613; DOI: 10.1016/j.farmac.2004.01.009.
  47. 47. R. Thirumurugan, D. Sriram, A. Saxena, J. P. Stables and P. Yogeeswari, 2,4-Dimethoxy phenylsemicarbazones with anticonvulsant activity against three animal models of seizures. Synthesis and pharmacological evaluation,(2006) 3106_3112.
  48. 48. P. Yogeeswari, R. Thirumurugan, R. Kavya, J. S. Samuel and J. P. Stables, 3-Chloro-2-methyl phenyl substituted semicarbazones: Synthesis and anticonvulsant activity,.(2004) 729_734.
  49. 49. P. Yogeeswari, D. Sriram, V. Veena, R. Kavya, R. Rakhra, J. V. Raghvendran, S. Mehta, R. Thirumurugan and J. P. Stables, Synthesis of arylsemicarbazones as potential anticonvulsants agents,(2005) 57_55; DOI: 10.1016/j.biopha 2004.04.013.
  50. 50. S. N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan and J. P. Stables, Evaluation ofnitrophenyl substituted semicarbazones for anticonvulsant properties,(1999) 923_925.
  51. 51. N. Aggarwal, P. Mishra, B. P. Nagori, R. Aggrawal and J. Jain, Anticonvulsant and neurotoxicity evaluation of some(4)-phenylsubstituted pyridyl semicarbazones,(2009) 245_249; DOI: 10.1016/j.ejps 2003.08.002.
  52. 52. A. S. Raja, S. N. Pandeya, S. S. Panda and J. P. Stables, Synthesis and anticonvulsant evaluation of semicarbazones of acetophenone Mannich bases,(2007) 302_307.
  53. 53. S. Mehta, P. Yogeeswari, D. Sriram and S. Induja, Microwave-assisted synthesis, anticonvulsant activity and quantum mechanical modeling of-(4-bromo-3-methyl phenyl) semicarbazones,,(2007) 45_55; DOI: 10.1631/ZUS 2007.B0045.
  54. 54. S. Mehta, P. Yogeeswari, D. Sriram, P. Kendyer, P. R. Kumar, S. Induja and J. P. Stables, Quantum mechanical modelling of4-(2,5-disubstituted phenyl) semicarbazones: Synthesis and anticonvulsant activity of4-(2,5-dimethyl phyenyl/2-fluoro-5-methyl phenyl) semicarbazones,(2006) 617_625.
  55. 55. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Ragvendran, K. Sudhansu and J. P. Stables, Discovery of-[2,6-dimethylphenyl) substituted semicarbazones as anticonvulsant effective against various animal model of seizures with GABA-T-inhibitory activity,(2005) 6202_6211; DOI: 10.1021/jm050283b.
  56. 56. F. Azam, T. A. Alkaskas, S. L. Khokra and O. Prakash, Synthesis of novel1-(naphtha[1,2-d] thiazol-2-yl) semicarbazides as potential anticonvulsant,.(2009) 203_211.
  57. 57. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzthiazole semicarbazones as novel anticonvulsant. The role of hydrophobic domain,(2007) 4178_4182; DOI: 10.1002/ardp.200800130.
  58. 58. S. Mehta, R. K. Pavana, P. Yogeeswari, D. Sriram, J. P. Stables, Heteroaryl-substituted semicarbazones. Synthesis and anticonvulsant activity of-(3-methyl pyridine-2-yl)-substituted semicarbazones,(2009) 1287_1293; DOI: 10.1002/jRet 5570430522.
  59. 59. N. Aggarwal and P. Mishra, Synthesis and evaluation of 4-substituted Semicarbazones of levulinic acid for anticonvulsant activity,(2005) 617_621; DOI: 10.1631/jZUS.2005.B0617.
  60. 60. M. Taroua, C. Ribuot, M. H. Pera, G. Tailandier, M. Fatome, J. D. Laval, P. Demengec and G. Leclerc, New _-, _- and _-semicarbazone and thiosemicarbazone 1,3-dithiolones as radioprotectors anticonvulsant activity,.(1996) 589_595; DOI: 10.1002chin.1996 461 40.
  61. 61. H. Rajak, R. Deshmukh, N. Aggarwal, S. Kashaw, M. D. Kharya and P. Mishra, Synthesis of novel 2,5-disubstituted-1,3,4-thiadiazoles for their potential anticonvulsant activity: Pharmacophoric model studies,(Weinheim)(2009) 453_461.
  62. 62. N. Siddiqui, M. F. Arshad and S. A. Khan, Synthesis of some new coumarin incorporated thiazoylsemicarbazones as anticonvulsants,(2009) 161_167.
  63. 63. I. Ponnilavarasan, S. Ganguly and V. Pandit, Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agents,(2010) 703_706.
  64. 64. J. R. Dimmock and G. B. Baker, Anticonvulsant activities of 4-bromobenzaldehyde semicarbazones,(1994) 648_655; DOI: 10.1111/j.1528-1157.1994.tb02486x.
  65. 65. S. N. Pandeya, H. Manjula and J. P. Stables, Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants,(2001) 121_124.
  66. 66. S. N. Pandeya, B. N. Singh and J. Mishra, Synthesis and biological activity of substituted arylsemicarbazones,(2007) 85_92.
  67. 67. S. N. Pandeya, S. Smitha and J. P. Stables, Anticonvulsant and sedative-hypnotic activities of-substituted isatin semicarbazones,(Weinheim)(2002) 129_134; DOI: 10.1002/1521-4184(200204).
  68. 68. S. N. Pandeya, S. Kohli, N. Siddiqui and J. P. Stables, Synthesis and anticonvulsant activities of 4--substituted arylsemicarbazones,(2003) 565_571.
  69. 69. S. N. Pandeya, A. S. Raja and J. P. Stables, Synthesis of isatin semicarbazones as novel anticonvulsant role of hydrogen bonding,(2002) 266_271.
  70. 70. A. Singh, C. Pande, P. Gahtori, S. N. Pandeya and J. P. Stables, Design and synthesis of some novel 4(4-substituted aryl) semicarbazones as anticonvulsant agents,(2010) 363_367; DOI: 10.4103 10250-474x70485.
  71. 71. N. Aggarwal and P. Mishra, Synthesis of 4-arylsubstituted semicarbazones of some terpenes as novel anticonvulsants,(2004) 260_264.
  72. 72. N. Aggrawal, R. Aggarwal, P. Mishra, J. S. Jain, S. K. Bansal and K. K. Jha, Design and evaluation of semicarbazones and thiosemicarbazones as novel anticonvulsants,(2008) 26_28.
  73. 73. J. R. Dimmock, K. K. Sidhu, R. S. Thayer, P. Mack, M. J. Duffy, R. S. Reid, J. W. Quail, U. Pugazhenthi, A. Ong, J. A. Bikker and D. F. Weaver, Anticonvulsant activities of some arylsemicarbazones, displaying potent oral activity in the maximal electroshock screen in rats acconpanied by high protective indices,(1993) 2243_2265; DOI: 10.1021/jm000689001.
  74. 74. J. R. Dimmock, K. K. Sidhu, S. D. Thumber, S. D. Basram, M. Chen, J. W. Quail, J. Yang, I. Rozas and D. F. Weaver, Some arylsemicarbazones possessing anticonvulsant activity,(1995) 287_301.
  75. 75. J. R. Dimmock, R. N. Puthucode, J. M. Smith, M. Hetherington, J. W. Quail, U. Pugazhenthi, R. Lecher and J. P. Stables, (Aryloxy) aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen,(1996) 3984_3997; DOI: 10.1021/jm9603025.
  76. 76. R. N. Puthucode, U. Pugazenthi, J. W. Quail, J. P. Stables and J. R. Dimmock, Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones,(1998) 595_607.
  77. 77. J. R. Dimmock, H. A. Semple, S. John, M. A. Beazely and G. D. Abrams, Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazones after oral dosing to rats,(1999) 260_262.
  78. 78. K. Ramu, G. N. Lam and H. Huges, In vivo metabolism and mass balance of 4[4-fluorophenylbenzaldehyde semicarbazone (CO102862) in rats,(2000) 1153_1161.
  79. 79. K. Ramu, G. N. Lam and B. Chin, Development of a high-performance liquid chromatorgraphy tandem mass spectrum of the method for the determination of pharmacokinetic of C0102802 in mouse, rat, monkey and dogs plasma,(2000) 1_15.
  80. 80. N. C. Lam, Sodium channel blocker compositions and the use thereof, Pat. W0 00/6 11 88, 19 Oct. 2000.
  81. 81. N. Micale, M. Zappala, S. Grazzo, G. Puja, G. Desarro, G. Ferreri, A. Desarro, L. Toma and C. Di Michali, Novel potent AMP/Kainate receptor antagonists : Synthesis and anticonvulsant activity of series of 2[(4-alkyl semicarbazono)-(4-aminophenyl) methyl)-4,5-methylene dioxy phenylacetic acid alkyl esters,(2002) 4433_4442.
  82. 82. N. Siddiqui, M. S. Alam and W. Ahsan, Synthesis, Anticonvulsant and toxicity evaluation of 2(1-indol-3yl)acetyl--substituted phenyl) hydrazine carbothioamides and their related heterocyclic derivatives,(2008) 445_459; DOI: 10.2478/v1007-008-0025-0.5.
  83. 83. S. Mehta, P. Yogeeswari, D. Sriram and J. P. Stables, Cyclization of the semicarbzone template of arylsemicarbazones: Synthesis and anticonvulsant activity of 4,5-(diphenyl)-2H-1,2,4-triazole-3-(4H)-one,(2009) 187_193; DOI: 10.1016/j.biopha.2006.04.002.
  84. 84. P. Czapinski, B. Blaszezyk and S. J. Czuczwar, Mechanism of action of antiepileptic drugs,(2005) 3_14.
  85. 85. V. I. Ilyin, D. D. Hodges, E. R. Whitmore, R. B. Carter, S. X. Cai and R. M. Woodward, V102862 (CO102862): A potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels,(2005) 801_812; DOI: 10.1038/sj.bjp.0706058.
  86. 86. P. Yogeeswari, D. Sriram, A. Brahmanandan, I. Sridharan, R. Thirumurugan and J. P. Stables, Synthesis of novel arylsemicarbazones as anticonvulsants with GABA-mediated mechanism,(2003) 57_68.
  87. 87. W. E. Stone and M. J. Javid, Quantititative evaluation of the action of anticonvulsants against different chemical convulsants,(1979) 66_78.
  88. 88. W. E. Stone and M. J. Javid, Anticonvulsant and convulsive effects of lidocaine: Comparison with those of phenytoin, and implication for mechanism of action concepts,(1988) 161_168.
  89. 89. R. L. McDonald and K. M. Kelly, Antiepileptic drug mechanism of action,(Suppl. 2S) (1995) 2_12.
  90. 90. P. Yogeeswari, J. V. Ragavendran, D. Sriram, V. Nageswari, R. Kavya, N. Srivastsan, K. Vanitha and J. P. Stables, Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach,(2007) 2459_2467; DOI: 10.1021/jm061431g.
  91. 91. B. Malawaska and A. Scatturin, Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs,(2003) 341_348.
  92. 92. J. Riss, J. Cloyd, J. Gates and S. Collins, Benzodiazepines in epilepsy pharmacology and pharmacokinetics,(2008) 64_86; DOI: 10.1111/j.1600-0404.2008.01004.x.
DOI: https://doi.org/10.2478/v10007-012-0030-1 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian, Slovenian
Page range: 263 - 286
Published on: Nov 6, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2012 Surendra Nath Pandeya, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.